MillerKAtkinsBMoodyML. Drug therapy for nocturnal enuresis. Drugs1992;44:47–56.
4.
Desmopressin for nocturnal enuresis. Med Lett1990;32:38–9.
5.
ShulmanLHMillerJLRoseLI. Desmopressin for diabetes insipidus, hemostatic disorders and enuresis. Am Fam Physician1990;42:1051–7.
6.
HiltonPHertogsKStantonSL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry1983;46:854–5.
7.
ValiquetteGAbramsGMHerbertJ. DDAVP in the management of nocturia in multiple sclerosis (abstract). Ann Neurol1992;31:577.
8.
EckfordSDSwamiKSJacksonSRAbramsPH. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol1994;74:733–5.
9.
EckfordSDCarterPGJacksonSRPenneyMDAbramsPH. An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia. Br J Urol1995;76:459–63.
10.
ValiquetteGHerbertJMeade-D'AliseraP. Desmopressin in the management of nocturia in patients with multiple sclerosis. Arch Neurol1996;53:1270–5.
11.
FredricksonS. Nasal desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neurol Scand1996;94:31–4.
12.
Desmopressin acetate. In: McEvoyGK, ed. AHFS drug information 1997. Bethesda, MD: American Society of Health-System Pharmacists, 1997:2460.
13.
JanknegtRAZweersHMMDelaereKPJKloetAGKhoeSGArendsenHJ. Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: A double-blind, randomized, multicenter study. J Urol1997;157:513–7.
14.
KinnACLarssonPO. Desmopressin: A new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol1990;24:109–12.
15.
BernsteinSAWillifordSL. Intranasal desmopressin-associated hyponatremia: A case report and literature review. J Fam Pract1997;44:203–8.
